- Current report filing (8-K)
August 05 2010 - 4:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2010
COMBINATORX, INCORPORATED
(Exact name of Registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
|
|
|
|
000-51171
|
|
04-3514457
|
|
(Commission File No.)
|
|
(IRS Employer Identification No.)
|
245 First Street
Third Floor
Cambridge, MA 02142
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code:
(617) 301-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition.
On August 5, 2010, CombinatoRx, Incorporated ("CombinatoRx") issued a press release relating to its results of operations and financial condition for the quarter ended June 30, 2010. The full text of CombinatoRx's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 2.02 of this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Press release of CombinatoRx, Incorporated dated August 5, 2010.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
COMBINATORX, INCORPORATED
|
|
|
By:
|
/s/ Justin A. Renz
|
|
|
|
Name: Justin A. Renz
|
|
|
|
Title: Senior Vice President,
|
|
|
|
Chief Financial Officer & Treasurer
|
|
Dated: August 5, 2010
|
|
|
Index to Exhibits
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Press release of CombinatoRx, Incorporated dated August 5, 2010.
|
Combinatorx (NASDAQ:CRXX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Combinatorx (NASDAQ:CRXX)
Historical Stock Chart
From Nov 2023 to Nov 2024
